XTR022

N/A

Report date: 2025/11/20 16:03:41

NME

Base Information

Drug NameXTR022

Drug Alias NameXTR-022

ClassificationRadiation-emitting products > Nuclides > Actinium > 225AcRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsProstatic Neoplasms, Castration-Resistant

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesBeijing Xiantong International Technology Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesBeijing Xiantong International Technology Co Ltd

Inactive CompaniesN/A

Active IndicationsProstatic Neoplasms, Castration-Resistant

Inactive IndicationsN/A

Other Information

ATC CodeN/A